Project Number 3R01CA227064-02S1 Agency/Funding Organization NCI Funding Year 2019 View Full Project Details for PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator KAVELAARS, ANNEMIEKE Principal Investigator First Name ANNEMIEKE Principal Investigator Last Name KAVELAARS Awardee Organization UNIVERSITY OF TX MD ANDERSON CAN CTR Awardee State Texas Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-591: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) FY Overall Cost $399,918 Funding Organization Agency/Funding Organization NCI Funding Organization Country United States Program Official ST GERMAIN, DIANE
